Identifying mechanism-of-action targets for drugs and probes
- 18 June 2012
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 109 (28), 11178-11183
- https://doi.org/10.1073/pnas.1204524109
Abstract
Notwithstanding their key roles in therapy and as biological probes, 7% of approved drugs are purported to have no known primary target, and up to 18% lack a well-defined mechanism of action. Using a chemoinformatics approach, we sought to "de-orphanize" drugs that lack primary targets. Surprisingly, targets could be easily predicted for many: Whereas these targets were not known to us nor to the common databases, most could be confirmed by literature search, leaving only 13 Food and Drug Administration-approved drugs with unknown targets; the number of drugs without molecular targets likely is far fewer than reported. The number of worldwide drugs without reasonable molecular targets similarly dropped, from 352 (25%) to 44 (4%). Nevertheless, there remained at least seven drugs for which reasonable mechanism-of-action targets were unknown but could be predicted, including the antitussives clemastine, cloperastine, and nepinalone; the antiemetic benzquinamide; the muscle relaxant cyclobenzaprine; the analgesic nefopam; and the immunomodulator lobenzarit. For each, predicted targets were confirmed experimentally, with affinities within their physiological concentration ranges. Turning this question on its head, we next asked which drugs were specific enough to act as chemical probes. Over 100 drugs met the standard criteria for probes, and 40 did so by more stringent criteria. A chemical information approach to drug-target association can guide therapeutic development and reveal applications to probe biology, a focus of much current interest.Keywords
This publication has 50 references indexed in Scilit:
- Large-scale prediction and testing of drug activity on side-effect targetsNature, 2012
- Chemical informatics and target identification in a zebrafish phenotypic screenNature Chemical Biology, 2011
- Small Molecule Probes of Cellular Pathways and NetworksACS Chemical Biology, 2010
- Spatial chemical distance based on atomic property fieldsJournal of Computer-Aided Molecular Design, 2010
- Predicting new molecular targets for known drugsNature, 2009
- The pharmacology of sigma-1 receptorsPharmacology & Therapeutics, 2009
- A crowdsourcing evaluation of the NIH chemical probesNature Chemical Biology, 2009
- Four-Dimensional Docking: A Fast and Accurate Account of Discrete Receptor Flexibility in Ligand DockingJournal of Medicinal Chemistry, 2008
- Quantifying the Relationships among Drug ClassesJournal of Chemical Information and Modeling, 2008
- How many drug targets are there?Nature Reviews Drug Discovery, 2006